In addition to pointing toward potential drug targets, genomic data can also provide researchers with an inkling of what the possible side effects of drugs targeting certain genes might be, writes Francis Collins at the NIH Director's Blog.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.